Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TANK-27: Long-term efficacy and safety of elobixibat for chronic constipation
jRCTs031200363Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic constipation comparing Elobixibat 10 mg with Placebo (2 arms). Started Oct 2021; status: completed.
02
Drugs
elobixibat
03
Conditions
chronic constipation
Beyond the preview
Go deeper on jRCTs031200363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200363.